| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID5071: Fezolinetant for untreated vasomotor symptoms associated with the menopause |
|
Medicine details |
|
| Medicine name | fezolinetant |
| Formulation | oral |
| Reference number | 4511 |
| Indication | Treatment of menopause-related Vasomotor Symptoms (Hot Flashes) |
| Company | Astellas Pharma Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/03/2023 |
| NICE guidance | ID5071: Fezolinetant for untreated vasomotor symptoms associated with the menopause |